breast cancer

WHO prequalifies first biosimilar medicine to increase life-saving breast cancer treatment

The World Health Organization (WHO), on Wednesday, prequalified its first biosimilar medicine – trastuzumab – in a move that could make this expensive, life-saving treatment more affordable and available to women globally.